Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran is granted a 40 percent rating for residuals of prostate cancer with erectile dysfunction from March 5, 2015 to May 20, 2015. Prior to this period and after May 21, 2015, the Veteran's condition warrants a 20 percent rating.

The deciding factor: The evidence shows that the Veteran experienced urinary frequency requiring daytime voiding no more frequent than every one to two hours, with nocturia of at most three to four times per night. This aligns with a 40 percent rating from March 5, 2015 to May 20, 2015.

Claimed conditions
Prostate cancer, Erectile Dysfunction
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
40%
Decision date
September 10, 2020
Citation
20059377

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 20059377.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.